JUMPSTARTER兩周公眾活動吸引逾10萬人參與
阿里巴巴創業者基金主辦的JUMPSTARTER今年首度舉辦大型線下創科活動,於11月8至19日期間吸引超過10萬人次參與。同時,第6屆阿里巴巴創業者基金/匯豐JUMPSTARTER 2023環球創業比賽亦於本月16至17日進行,經過來自85個國家及地區逾1,000家參賽者共15場的路演比賽,由生物科技及生命科學領域Allegrow Biotech奪得冠軍。
阿里巴巴香港創業者基金執行董事兼行政總裁周駱美琪表示,阿里巴巴創業者基金一致直力支持初創發展,尤其希望通過大型創業比賽JUMPSTARTER,攜手社會各界支持具潛力的初創項目成長,希望這些參與者可更多認識創科的發展。阿里巴巴香港創業者基金也將繼續在支持初創發展方面推陳出新,並積極參與推動香港成為國際科創中心。(ka/cy)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.